Marinus Verwijs, CHIEF TECHNICAL OFFICER at Aerovate Therapeutics, Inc. (AVTE), sold 10,600 shares at $25.68 ($277K) on 2024-03-19, disclosed to the SEC on 2024-03-20.
Scheduled sale ($277k) by CHIEF TECHNICAL OFFICER under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $25.68 | 2,536 | $65K | 23.6% |
| 2 | $25.68 | 2,536 | $65K | 23.6% |
| 3 | $26.46 | 2,764 | $73K | 26.4% |
| 4 | $26.46 | 2,764 | $73K | 26.4% |
| Total | $26.09 avg | 10,600 | $277K | 100% |
| Filing → |
| AVTE | SELL | 2024-04-03 | $264K | — | Filing → |
| AVTE | SELL | 2023-11-03 | $10K | — | Filing → |
| AVTE | SELL | 2023-05-05 | $16K | — | Filing → |